IPC
JAZZ icon

Independent Portfolio Consultants’s Jazz Pharmaceuticals JAZZ Stock Holding History

Independent Portfolio Consultants’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$181K Sell
1,162
-518
-31% -$79.2K 0.08% 307
2017
Q1 		$244K Sell
1,680
-715
-30% -$93.1K 0.08% 293
2016
Q4 		$261K Buy
2,395
+70
+3% +$7.8K 0.09% 282
2016
Q3 		$282K Sell
2,325
-70
-3% -$9.44K 0.09% 272
2016
Q2 		$338K Buy
2,395
+160
+7% +$23.6K 0.11% 263
2016
Q1 		$292K Buy
2,235
+50
+2% +$6.22K 0.08% 286
2015
Q4 		$307K Buy
2,185
+20
+0.9% +$2.77K 0.09% 273
2015
Q3 		$288K Sell
2,165
-120
-5% -$20.7K 0.06% 305
2015
Q2 		$402K Sell
2,285
-20
-0.9% -$3.59K 0.08% 275
2015
Q1 		$398K Buy
2,305
+870
+61% +$149K 0.08% 272
2014
Q4 		$235K Sell
1,435
-1,000
-41% -$166K 0.05% 338
2014
Q3 		$391K Buy
2,435
+2,315
+1,929% +$356K 0.11% 315
2014
Q2 		$18K Buy
+120
New +$16.6K 0.01% 785
2014
Q1 		– Sell
-3,375
Closed -$427K – 465
2013
Q4 		$427K Sell
3,375
-1,325
-28% -$137K 0.15% 287
2013
Q3 		$432K Sell
4,700
-285
-6% -$23K 0.17% 257
2013
Q2 		$343K Buy
+4,985
New +$305K 0.15% 294

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Independent Portfolio Consultants's JAZZ Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Jazz Pharmaceuticals (JAZZ) stake by 31% in Q2 2017, selling an estimated $79.2K and leaving 1,162 shares worth $181K. The position accounts for 0.08% of the portfolio, ranked #307.

Independent Portfolio Consultants first reported a position in JAZZ in Q2 2013 and has held it in 16 quarters since. The position peaked at $432K in Q3 2013. 319 funds tracked by Wall St. Rank hold JAZZ as of Q2 2017.

  • Independent Portfolio Consultants held 1,162 shares of Jazz Pharmaceuticals worth $181K as of Q2 2017.
  • Independent Portfolio Consultants sold 518 Jazz Pharmaceuticals shares in Q2 2017, an estimated $79.2K.
  • Jazz Pharmaceuticals made up 0.08% of Independent Portfolio Consultants's portfolio in Q2 2017, its #307 holding.
  • Independent Portfolio Consultants first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • Independent Portfolio Consultants's Jazz Pharmaceuticals position peaked at $432K in Q3 2013.
  • 319 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.